Cargando…

Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom

BACKGROUND AND AIMS: To elicit utility values for five health states corresponding to increasing severity of hepatic encephalopathy, from members of the general public in the UK. The health states studied were Conn grades 0, 1, 2, 3 and 4. METHODS: Interviewer-administered time trade-off (TTO) and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Guest, Julian F, Nanuwa, Kam, Barden, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070646/
https://www.ncbi.nlm.nih.gov/pubmed/24917331
http://dx.doi.org/10.1186/1477-7525-12-89
_version_ 1782322720310034432
author Guest, Julian F
Nanuwa, Kam
Barden, Rob
author_facet Guest, Julian F
Nanuwa, Kam
Barden, Rob
author_sort Guest, Julian F
collection PubMed
description BACKGROUND AND AIMS: To elicit utility values for five health states corresponding to increasing severity of hepatic encephalopathy, from members of the general public in the UK. The health states studied were Conn grades 0, 1, 2, 3 and 4. METHODS: Interviewer-administered time trade-off (TTO) and standard gamble (SG) utilities were elicited for the five health states from a random sample of 200 members of the general public in the UK, using health state descriptions validated by clinicians and members of the general public. RESULTS: Respondents’ mean age was 49.5 years and 49% were female. Mean utilities were 0.962 (TTO) and 0.915 (SG) for Conn grade 0; 0.912 (TTO) and 0.837 (SG) for Conn grade 1; 0.828 (TTO) and 0.683 (SG) for Conn grade 2; 0.691 (TTO) and 0.489 (SG) for Conn grade 3; and 0.429 (TTO) and 0.215 (SG) for Conn grade 4. The TTO and SG values between the five Conn grades were significantly different (p < 0.001). Additionally, the TTO value was significantly higher than the SG value for the corresponding state (p <0.0001). CONCLUSION: These findings quantify how different Conn grades and level of response to treatment may impact on the health-related quality of life of patients with hepatic encephalopathy. There were greater preference values for lower levels of disease, with the highest value associated with Conn grade 0. These health state preference values can be used to estimate the outcomes of different interventions for hepatic encephalopathy in terms of quality-adjusted life years.
format Online
Article
Text
id pubmed-4070646
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40706462014-06-26 Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom Guest, Julian F Nanuwa, Kam Barden, Rob Health Qual Life Outcomes Research BACKGROUND AND AIMS: To elicit utility values for five health states corresponding to increasing severity of hepatic encephalopathy, from members of the general public in the UK. The health states studied were Conn grades 0, 1, 2, 3 and 4. METHODS: Interviewer-administered time trade-off (TTO) and standard gamble (SG) utilities were elicited for the five health states from a random sample of 200 members of the general public in the UK, using health state descriptions validated by clinicians and members of the general public. RESULTS: Respondents’ mean age was 49.5 years and 49% were female. Mean utilities were 0.962 (TTO) and 0.915 (SG) for Conn grade 0; 0.912 (TTO) and 0.837 (SG) for Conn grade 1; 0.828 (TTO) and 0.683 (SG) for Conn grade 2; 0.691 (TTO) and 0.489 (SG) for Conn grade 3; and 0.429 (TTO) and 0.215 (SG) for Conn grade 4. The TTO and SG values between the five Conn grades were significantly different (p < 0.001). Additionally, the TTO value was significantly higher than the SG value for the corresponding state (p <0.0001). CONCLUSION: These findings quantify how different Conn grades and level of response to treatment may impact on the health-related quality of life of patients with hepatic encephalopathy. There were greater preference values for lower levels of disease, with the highest value associated with Conn grade 0. These health state preference values can be used to estimate the outcomes of different interventions for hepatic encephalopathy in terms of quality-adjusted life years. BioMed Central 2014-06-10 /pmc/articles/PMC4070646/ /pubmed/24917331 http://dx.doi.org/10.1186/1477-7525-12-89 Text en Copyright © 2014 Guest et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Guest, Julian F
Nanuwa, Kam
Barden, Rob
Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title_full Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title_fullStr Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title_full_unstemmed Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title_short Utility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom
title_sort utility values for specific hepatic encephalopathy health states elicited from the general public in the united kingdom
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070646/
https://www.ncbi.nlm.nih.gov/pubmed/24917331
http://dx.doi.org/10.1186/1477-7525-12-89
work_keys_str_mv AT guestjulianf utilityvaluesforspecifichepaticencephalopathyhealthstateselicitedfromthegeneralpublicintheunitedkingdom
AT nanuwakam utilityvaluesforspecifichepaticencephalopathyhealthstateselicitedfromthegeneralpublicintheunitedkingdom
AT bardenrob utilityvaluesforspecifichepaticencephalopathyhealthstateselicitedfromthegeneralpublicintheunitedkingdom